Document is current
Any future updates will be listed below
-
Authors
Lo, Serigne N.
Hong, Angela M.
Haydu, Lauren E.
Ahmed, Tasnia
Paton, Elizabeth J.
Steel, Victoria
Hruby, George
Tran, Anh
Morton, Rachael L.
Nowak, Anna K.
Vardy, Janette L.
Drummond, Katharine J.
Dhillon, Haryana M.
Mandel, Catherine
Scolyer, Richard A.
Middleton, Mark R.
Burmeister, Bryan H.
Thompson, John F.
Fogarty, Gerald B. https://orcid.org/0000-0002-0764-578X
-
Funding
Funding for this research was provided by:
Cancer Australia (1084046)
- License Information
-
More Information
Article History
Received: 11 December 2018
Accepted: 4 July 2019
First Online: 5 August 2019
Ethics approval and consent to participate
: The study protocol has been approved by Cancer Institute NSW Clinical Research Ethics Committee (Reference 2007C/11/032) on 1 April 2009. The project was transferred to the Sydney Local Health District Ethics Review Committee (RPAH Zone), and ethical approval was granted on 5 February 2014 (References X13-0329 and HREC/13/RPAH/465). The study was carried out in compliance with national and state legal and regulatory requirements and according to the International Principles of Good Clinical Practice (ICH-GCP). As such all trial participants gave informed consent prior to joining the trial.
: Not applicable.
: The authors declare that they have no competing interests.
